Wyoming Health Innovation Living Lab Case Study

Identifying and addressing mild cognitive impairment (MCI) and other neurological conditions is difficult, subjective, and costly. In a partnership with the Wyoming Health Innovation Living Lab (WHILL), Canary Speech’s vocal biomarker technology was introduced as a solution to these challenges, aiming to provide objective data for assessing wellness and improving patient outcomes.

Collaborating with WHILL, the effectiveness of Canary Speech’s vocal biomarker technology was studied over six months, showing significant positive impacts in increasing awareness of cognitive decline, aiding in screening for such decline, and creating additional revenue opportunities for healthcare providers. By deploying this technology both within and outside clinical settings, WHILL demonstrated its potential to enhance patient care while streamlining diagnostic processes and billing procedures. The included case study provides the goals and findings of the joint analysis.